This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

March 18, 2021
Delivered DigitallyCentral European Time

SideROS

Profile

SideROS is a preclinical-stage biotech company focused on accelerated development of innovative small molecules targeting tumor cells metabolism in cancers with poor prognosis. We trigger persistent cancer cells death through iron interfering metabolism, with ironomycin, our first lead candidate in hematological malignancies and solid tumors.